Skip to main content
Assets
Axon Enterprise logo
AXON.NASDAQ
Axon Enterprise
Industrials · Aerospace & Defense

Public safety technology provider combining devices, software, and AI-enabled evidence workflows for law enforcement and emergency response.

HQ: United StatesListed: United States

Historical AI Opinions

Audit every published iPulse AI forecast batch and immutable historical research document for Axon Enterprise.

Axon Enterprise Inc. (AXON.NASDAQ) AI OPINIONS & ADVISOR ANALYSIS

Read the selected AI Advisor’s complete report, scenarios and forecast. Select Consensus for its investment thesis and a preview of advisor weights. Eligible access unlocks all 14 advisor reports and comparisons.

Updated on 20 September 2026Deep analysis 20 September 2026

25 min readAudit All Past Forecasts
AI Researcher
Universal Investor AI advisor icon
Opus 5

Universal Investor AI

The Polymath Framework

Model rating

Buy

5-Year Return Est.

+68.9%

AXON.NASDAQ does not currently pay dividends

Historical prices and published forecast

Historical prices and published forecastObserved prices and the selected advisor's published projection share a split-adjusted price basis. Prices after the forecast start are later observations, not information known at publication. Forecasts are uncertain. Values in USD.8.28242.51476.74710.97945.2Sep 2021Mar 2024Sep 2026Mar 2029Sep 2031Forecast starts
  • Observed price
  • Published advisor forecast
Observed prices and the selected advisor's published projection share a split-adjusted price basis. Prices after the forecast start are later observations, not information known at publication. Forecasts are uncertain. Values in USD.
Quarterly Events ForecastPrice targets, total returns and complete scenario reasoning

Forecast prices in USD. Returns are cumulative from the forecast anchor. Swipe horizontally to read every column.

QuarterForecastTotal returnScenario
$466+4.0%

Q3 reports early November against consensus of $1.94 EPS on $935 million revenue [8]. Convertible overhang clears after settlement, and an oversold technical base forms, but a 5% ten-year yield caps the rebound.

$442-1.2%

February's FY2027 guidance frames another year of elevated inventory and memory-cost inflation. A conservative margin outlook and full-year free cash flow below expectations trigger renewed de-rating despite backlog remaining above $15 billion.

$469+4.7%

Q1 2027 shows the first working-capital reversal as inventory builds moderate per management guidance [10]. Cash conversion improves visibly, and softening US inflation lets long yields ease, supporting duration-sensitive growth names.

$492+10.0%

Software and Services growth holds above 30% while non-DEMS revenue compounds. International AI Era Plan adoption adds ARR. The CentralSquare-Carbyne trial outcome in May 2027 removes a discrete litigation overhang.

$512+14.4%

Q3 2027 confirms free cash flow exceeding ten percent of revenue for the first time since 2024. Multiple stabilises as the market re-rates cash quality rather than raising growth expectations.

$492+9.8%

FY2028 guidance implies deceleration toward the mid-twenties as large US agency upgrade cycles mature. Investors discount the slowdown immediately, offsetting improved conversion; state-level ALPR legislation adds headline risk.

$521+16.4%

Axon 911 wins and Dedrone federal infrastructure contracts demonstrate a credible second platform. Bookings reaccelerate, and an easing rate regime lifts the valuation investors assign to distant software earnings.

$547+22.2%

Gross margin recovers above sixty percent as software mix outgrows devices and memory pricing normalises post-AI-capex peak. Operating leverage finally appears in GAAP results, not only adjusted metrics.

$569+27.1%

Counter-drone and international revenue diversify away from US municipal budgets. Steady execution plus moderating stock-compensation intensity narrows the gap between enterprise growth and per-share growth.

$586+30.9%

FY2029 guidance settles into a durable low-twenties growth and thirty percent adjusted EBITDA profile. The market rewards predictability modestly; the starting multiple still limits upside per unit of earnings.

$610+36.1%

Free cash flow scales faster than revenue as the inventory cycle fully unwinds and cloud infrastructure spending flattens. Buybacks begin offsetting convertible and compensation dilution more meaningfully.

$628+40.2%

Competitive pressure from Motorola's full-stack bundle constrains pricing in renewals. Growth remains solid but unspectacular; the stock tracks earnings with no further multiple expansion in a neutral rate regime.

$653+45.8%

Year-end contract cycle delivers strong bookings from international and federal channels. Backlog extends beyond $25 billion on my estimate, reinforcing the annuity framing and supporting a stable premium valuation.

$633+41.4%

The $1.0 billion 2030 senior notes maturity approaches alongside the 2031 convertible, prompting refinancing questions. A cautious guidance year and dilution arithmetic reassert themselves briefly on the multiple.

$659+47.1%

Refinancing completes at manageable cost given improved cash generation. Renewal economics on ten-year evidence contracts demonstrate genuine pricing power, validating the embedded-network thesis for institutional holders.

$678+51.5%

Autonomous drone-as-first-responder and AI report products reach commercial scale, though regulatory disclosure requirements limit pricing. Revenue approaches double the 2026 base, with cash earnings compounding faster.

$699+56.1%

Maturing growth profile attracts quality-compounder capital rather than momentum money. Lower share-price variability accompanies steadier earnings, and the valuation gradually converges toward a defensible high-twenties cash multiple.

$713+59.2%

Growth moderates into the high teens as state and local penetration deepens. Incremental upside now depends on international and non-police adjacencies rather than the core US agency franchise.

$734+64.0%

Convertible conversion or settlement near maturity clarifies the final share count, removing residual dilution uncertainty. Per-share cash earnings visibility improves and supports incremental multiple stability.

$756+68.9%

Horizon close: roughly $10 billion revenue and $1.5 billion cash earnings on my estimate, capitalised near a $58 billion equity value. Returns came from compounding, not re-rating.

1. Investment Thesis — Base Case

The central tension is that Axon's enterprise compounds faster than its per-share value. Backlog of $15.1 billion and 39% ARR growth make revenue near-contractual, but roughly $600 million of annual stock compensation, serial acquisitions and a fresh $1.0 billion convertible siphon a large share of that growth before it reaches shareholders. The base case assumes revenue compounds in the low-to-mid twenties from an FY2026 level near $3.7 billion, adjusted EBITDA margin drifts toward 30%, inventory unwinds from 2027 and the multiple continues to compress slowly. Result: solid appreciation driven by earnings, not re-rating.

  • FY2026 revenue near $3.7 billion at 25.5% adjusted EBITDA implies roughly $940 million, my estimate.
  • Deducting guided stock compensation leaves about $335 million, over 110x enterprise value today.
  • By 2031, roughly $10 billion revenue and $1.5 billion cash earnings supports a $55-60 billion market value.

2. Scenarios & Signals

2.1. Bull Case

The bull case activates when cash arrives and rates retreat at the same time. Inventory normalisation from 2027 converts adjusted EBITDA into visible free cash flow, which validates the software mix shift, which in turn justifies a premium multiple just as falling Treasury yields reduce the discount applied to 2030 earnings. Add one large Axon 911 statewide win and counter-drone becoming a federal programme of record, and the compounding narrative returns with cash-flow proof attached. Shares outrun earnings substantially.

2.2. Bear Case

The bear case begins the quarter inventory stops being the excuse. If conversion stays below 8% of revenue while memory costs bite and normalised bookings decelerate toward the high teens, investors reclassify Axon from compounder to capital-hungry hardware integrator. Statutory ALPR restrictions then remove the fastest-growing software cohort, goodwill from Carbyne and Prepared faces scrutiny, and dilution keeps growing the share count. A reset toward five times sales follows, and the de-rating overwhelms revenue growth.

2.3. Behavioral Alpha Signals

Sentiment, repricing cycle, crowd narrative, catalyst, and macro alignment.

Expected Volatility Regime

LowModerateHighExtreme

Greed and Fear Index

-100 Fear0+100 Greed
-35

Cycle Position

The thesis is unwinding and reflexive decline is underway.

EarlyAwareMomentumOvershootReversalCapit.StabilizeREVERSAL
Figure: Advisor position within the seven-stage market-recognition cycle. The highlighted point marks Reversal.

What does Media Tell? (Crowd Consensus)

The consensus treats Axon as a broken momentum trade rather than a broken business: down 27% year to date and roughly 45% from its 2025 high, with sell-side targets still scattered between $600 and $825 [8][30]. The anchoring bias is the old 20x-sales print. Bulls recite $15.1 billion of backlog; bears recite 0.36% free-cash-flow yield. Both are pricing narrative, not conversion.

What Crowds Get Wrong? (Alpha/Value Gap)

Modest underpricing, with an important caveat. The crowd has correctly punished the cash-flow gap but is conflating two distinct problems: a working-capital build that management says moderates after 2026 [10], and stock-based compensation near $600 million that does not [11]. The first is temporary and reverses into cash; the second is permanent and belongs in owner earnings. Markets that de-rate for the reversible drag while backlog compounds 41% [4] create the gap. It is narrow, not gaping.

When will Value Gap Repricing Happen? (Repricing Catalyst)

Watch the Q4 2026 and Q1 2027 cash-flow statements, reported February and May 2027. A free-cash-flow print exceeding 10% of revenue alongside reiterated 30%-plus growth would convert the adjusted-EBITDA story into verified cash. The first sign of repricing is multiple expansion on an in-line revenue quarter.

How is Asset Influenced by Macro Regime?

The macro wind is squarely in its face. With the 10-year near 5.0% and the Fed's median dot implying further tightening, terminal-value equities carry the heaviest discount-rate burden, and Axon's earnings sit almost entirely beyond 2030. A secondary channel bites too: the AI capex cycle inflates memory prices inside Axon's hardware bill of materials [3]. Thesis sensitivity to a rate-regime pivot is extreme.

3. Positive & Negative Factors, Risks & Opportunities

3.1. Base-Case Forces

Near-certain positive forces

Top Drivers / Tailwinds

Structural or operating forces that support this advisor thesis. These forces are treated as part of the base case (more than 60% probability of occurrence).

Scroll to view all columns

Top Drivers / Tailwinds with asset-specific estimated impacts and thesis rationale
Driver / TailwindCategoryEst. stock-price impactEst. earnings impactWhy it matters
Backlog AS A Contracted AnnuityCompetitive Positioning+45%+120%Follow the paper trail: contracted backlog reached $15.1 billion, up 41%, with ARR of $1.6 billion, up 39% [4][5]. That ledger converts mechanically into revenue over five to ten years regardless of the macro tape, which is why guidance was raised to 32%-34% growth mid-tariff [3]. Switching costs across evidence, dispatch and devices make attrition rare, so this visibility persists across the horizon.
Software MIX Bends THE Margin CurveInnovation And Product+30%+55%The mix shift is the mechanism that eventually rescues the multiple. Roughly one third of Q2 software revenue came from outside digital evidence management, and that third grew about 70% [32], while Software and Services revenue of $398 million rose 36% [1]. Software carries structurally higher incremental margin than TASER and camera hardware, so each year of mix shift lifts group gross margin and cash earnings.
Inventory Unwind Releases Trapped CASHOperational Efficiency+25%+40%Free cash flow collapsed 77% to $75 million in 2025 [9], and TTM free cash flow is only $133 million against $3.22 billion of revenue. Management states inventory investment moderates after 2026, which it expects to improve long-term conversion [10]. Because the drag is working capital rather than structural economics, the reversal mechanically converts EBITDA into cash and removes the single loudest bear argument.
Public Safety Spends Through RecessionsSector And Industry+22%+45%Axon sells into municipal, state and federal budgets that are politically protected during downturns; police payrolls and evidence obligations are statutory, not discretionary. Dedrone counter-drone already runs at a $100 million quarterly rate on infrastructure-protection demand, and international agencies adopt the AI Era Plan at rates matching US customers [10]. With claimed penetration near 15% of state and local TAM [31], the runway outlasts any single budget cycle.

Near-certain negative forces

Top Frictions / Headwinds

Expected frictions that can slow, cap, or damage this advisor thesis. These forces are treated as part of the base case (more than 60% probability of occurrence).

Scroll to view all columns

Top Frictions / Headwinds with asset-specific estimated impacts and thesis rationale
Friction / HeadwindCategoryEst. stock-price impactEst. earnings impactWhy it matters
THE Discount RATE HammerMacroeconomic And Macrofinancial-30%+0.0%A stock priced at 11.5x TTM sales and 86.8x TTM EV/EBITDA is a duration instrument. The US 10-year closed at 4.998% on September 18 after a unanimous Fed hike to 3.75%-4.00%, with the median dot implying another increase. Every 50bp of term-premium repricing compresses terminal-value multiples on Axon far more than on cash-generative peers; this is what halved the stock while revenue accelerated [7][8].
THE Dilution Wedge Behind Adjusted EbitdCapital Allocation-22%-18%Stock-based compensation guided to $590-620 million for FY2026 [11][12] equals roughly 64% of guided adjusted EBITDA on my arithmetic, so adjusted profit and shareholder profit diverge sharply. Layer on $1.75 billion of senior notes, a $494.7 million ATM programme [18] and a fresh $1.0 billion 0% convertible due 2031 [14], and enterprise growth leaks before it reaches per-share value. The capped calls blunt, not eliminate, this.
Memory Costs TAX THE Hardware BOMOperational Efficiency-14%-12%The AI capex boom that lifts semiconductor suppliers taxes Axon's bill of materials. Management flagged rising component costs, especially memory, offsetting a Q2 tariff refund [3], while Q1 gross margin fell 150bps on tariffs and Dedrone mix [2]. Gross margin has already slid from 61.2% in 2023 to 59.7% in 2025. Devices still generated $507 million of Q2 revenue [1], so hardware inflation remains a persistent earnings drag.
ALPR Politics AS Category RISKRegulatory-12%-8.0%Two dozen Texas jurisdictions moved to remove automated plate readers and Governor Abbott halted state funding [25]; Tallahassee suspended Flock and Motorola contracts outright [26]. Axon is winning share from Flock on audited, retention-limited implementations [23][24], yet Tempe approved a $7 million contract only after ALPR capability was stripped out [28]. Statute, not contract language, will decide the category, capping a growth vector the market had been underwriting.

3.2. Risks & Opportunities

Plausible downside scenarios

Tail Risks

Less likely downside scenarios that could materially hurt the outcome if they occur.

Scroll to view all columns

Tail risks with plausibility, asset-specific potential impact and scenario rationale
Tail scenarioChance of OccurringStock Price ImpactWhy plausible / what changes
Growth Breaks Twenty AND THE Multiple Resets30%-40%The trigger would be a 2028-2029 guidance cut as the largest US agencies complete their upgrade cycles and normalised bookings decelerate toward the high teens, while free cash flow still lags adjusted EBITDA. Note the flag: a newly introduced five-year normalised bookings metric appeared exactly as gross bookings growth fell to 20% [31]. At 10x forward sales, deceleration below 20% with weak conversion compresses the multiple toward 5x. Below 50% because backlog of $15.1 billion cushions at least three years of revenue.
Statutory Surveillance Clampdown25%-30%A cluster of state legislatures enacting retention, sharing and AI-disclosure statutes during 2027-2029, following California SB 524 [12] and the Texas funding halt [25], would freeze ALPR, Draft One and fleet-camera pipelines simultaneously. That removes the fastest-growing non-DEMS software cohort and invites municipal contract renegotiation, hitting both ARR growth and the premium multiple. Probability remains below 50% because the same politics currently transfer business toward Axon's audited implementation [23][24], and body cameras enjoy bipartisan support that plate readers lack.

Plausible upside scenarios

Tail Opportunities

Less likely upside scenarios that could materially improve the outcome if they occur.

Scroll to view all columns

Tail opportunities with plausibility, asset-specific potential impact and scenario rationale
Tail scenarioChance of OccurringStock Price ImpactWhy plausible / what changes
CASH Conversion Inflection Meets Easing35%+45%The decisive combination: inventory normalisation lands in 2027 just as inflation rolls over and the Fed reverses the 2026 tightening. Free cash flow conversion moving from under 5% of revenue toward 15-20% would convert an unprovable adjusted-EBITDA story into a verifiable cash story, while a falling 10-year yield lifts the multiple investors pay for 2030 earnings. Expect recognition across 2027-2028 earnings prints. It stays below 50% because both legs must fire together, and management has missed its own conversion timeline once already [10].
AXON 911 Displaces THE Legacy Stack30%+38%Prepared plus Carbyne, bought at a $625 million valuation [19], gives Axon a call-to-closure path into 911 call handling, a market dominated by ageing CAD vendors [21]. A handful of large metropolitan or statewide wins during 2028-2030 would validate a second software platform of comparable scale to digital evidence management, re-accelerating ARR above 40% and justifying a premium multiple on a larger base. Probability stays under 50% because 911 procurement is slow, entrenched and now litigated: CentralSquare's patent trial against Carbyne is set for May 2027 [20].

5. References & Context

Search behavior, retained evidence, supplied context, and response token details.
Researcher modeExternal search used

External web search was used. The retained search terms and consulted sources are shown below.

Context supplied to the model

Public-safe inputs retained with this immutable forecast publication.

  1. 01

    Market data

    inmemory_base_placeholders__latest_eod_close_price_with_stats_and_fundamentals__var1

  2. 02

    Global context in this run

    Used

  3. 03

    Fundamental data in this run

    Used

  4. 04

    Global context

    Standard global market and cross-asset context

  5. 05

    Subject context

    Equity-specific subject and market context

  6. 06

    Task framework

    Standard investment-forecast task guidelines

  7. 07
    Universal Investor AI advisor icon

    Advisor framework

    Universal Investor The Polymath

  8. 08

    Forecast output requested

    Equity Extended Investment Thesis (4 Quadrants and Alpha Asymmetry) + Pct Change Timeseries for Close Price with Rationale, (5Y Quarterly)

03

Global context snapshot

2026 Year-to-Date Global Market and World-Events Context Through September 20

Download Archived Snapshot

Coverage 2026-01-01 to 2026-09-20 · Knowledge cutoff 2026-09-20

January 1-September 20, 2026: monetary tightening, energy security, trade restrictions, AI financing and divergent growth; five leading market themes.

Fed raised rates to 3.75%-4.00%; ECB hike is in force and BOJ increase starts September 24. Markets through September 18, bitcoin through September 19.

Top 3 market shifts from 2026 Year-to-Date Global Market and World-Events Context Through September 20
Top 3 Market Shifts From FileDateStatus
Renewed monetary tightening amid persistent inflation2026-01-30ACTIVE POLICY REGIME
Iran/Hormuz conflict and wider energy-security disruption2026-02-28ONGOING
Tariff legal reset and strategic supply restrictions2026-02-20ACTIVE POLICY REGIME

Representative Sources of the Context File

And more sources from the retained context package.

02

Fundamental context

Income statement

9 fields

depreciationAndAmortization · ebit · ebitda · grossProfit · +5 more fields

Balance sheet

12 fields

cash · commonStockSharesOutstanding · longTermDebt · netDebt · +8 more fields

Cash flow

5 fields

capitalExpenditures · dividendsPaid · freeCashFlow · salePurchaseOfStock · +1 more field

annual: 2014-12-31–2025-12-31, 12 periods; quarterly: 2023-09-30–2026-06-30, 12 periods

Currencies cited: USD (quote USD; primary reporting USD; converted/valuation USD).

Search terms retained

  1. 1.Axon Enterprise Q2 2026 results revenue guidance
  2. 2.Axon stock decline 2026 AXON shares fall
  3. 3.Axon $1 billion 0% convertible senior notes 2031 capped call pricing September 2026
  4. 4.Axon Flock Safety ALPR license plate reader city contracts ban 2026
  5. 5.Axon acquisition Carbyne Prepared 2026 purchase price stock-based compensation dilution share count

Sources retained for this advisor

Original published forecast

Inspect the original revision and sealed receipt when a public record is available. Integrity verification is separate from forecast accuracy.